StonvexLoading…
StonvexStonvexStonvexCore line items from NOVT's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $980.60M | $949.25M | $881.66M | $860.90M |
Operating Income | $94.01M | $110.58M | $110.50M | $103.08M |
Net Income | $53.83M | $64.09M | $72.88M | $74.05M |
EPS (Diluted) | $1.47 | $1.77 | $2.02 | $2.06 |
Total Assets | $1.81B | $1.39B | $1.23B | $1.24B |
Total Liabilities | $492.82M | $642.81M | $552.60M | $663.63M |
Cash & Equivalents | $380.87M | $113.99M | $105.05M | $100.11M |
Free Cash Flow OCF − CapEx | $48.43M | $141.35M | $100.11M | $71.14M |
Shares Outstanding | 35.67M | 35.94M | 35.81M | 35.71M |